Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1968 1
1969 1
1970 1
1971 2
1972 1
1973 2
1975 2
1977 2
1978 1
1979 1
1980 1
1981 3
1986 1
1987 1
1988 2
1989 5
1990 4
1991 1
1992 4
1993 2
1994 4
1995 3
1996 1
1997 1
1999 4
2000 2
2001 4
2002 1
2003 1
2004 3
2005 1
2006 4
2007 2
2008 2
2009 3
2010 1
2011 7
2012 4
2013 4
2015 2
2016 1
2017 1
2018 2
2019 3
2020 2
2021 5
2022 5
2023 4
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

114 results

Results by year

Filters applied: . Clear all
Page 1
Low-dose targeted radionuclide therapy renders immunologically cold tumors responsive to immune checkpoint blockade.
Patel RB, Hernandez R, Carlson P, Grudzinski J, Bates AM, Jagodinsky JC, Erbe A, Marsh IR, Arthur I, Aluicio-Sarduy E, Sriramaneni RN, Jin WJ, Massey C, Rakhmilevich AL, Vail D, Engle JW, Le T, Kim K, Bednarz B, Sondel PM, Weichert J, Morris ZS. Patel RB, et al. Among authors: rakhmilevich al. Sci Transl Med. 2021 Jul 14;13(602):eabb3631. doi: 10.1126/scitranslmed.abb3631. Sci Transl Med. 2021. PMID: 34261797 Free PMC article.
NK cells propagate T cell immunity following in situ tumor vaccination.
Jin WJ, Jagodinsky JC, Vera JM, Clark PA, Zuleger CL, Erbe AK, Ong IM, Le T, Tetreault K, Berg T, Rakhmilevich AL, Kim K, Newton MA, Albertini MR, Sondel PM, Morris ZS. Jin WJ, et al. Among authors: rakhmilevich al. Cell Rep. 2023 Dec 26;42(12):113556. doi: 10.1016/j.celrep.2023.113556. Epub 2023 Dec 13. Cell Rep. 2023. PMID: 38096050 Free PMC article.
Interleukin-12 as an in situ cancer vaccine component: a review.
Cheng EM, Tsarovsky NW, Sondel PM, Rakhmilevich AL. Cheng EM, et al. Among authors: rakhmilevich al. Cancer Immunol Immunother. 2022 Sep;71(9):2057-2065. doi: 10.1007/s00262-022-03144-1. Epub 2022 Jan 13. Cancer Immunol Immunother. 2022. PMID: 35024897 Free PMC article. Review.
Roles of CD4+ T cells as mediators of antitumor immunity.
Kravtsov DS, Erbe AK, Sondel PM, Rakhmilevich AL. Kravtsov DS, et al. Among authors: rakhmilevich al. Front Immunol. 2022 Sep 9;13:972021. doi: 10.3389/fimmu.2022.972021. eCollection 2022. Front Immunol. 2022. PMID: 36159781 Free PMC article. Review.
Short-course neoadjuvant in situ vaccination for murine melanoma.
Aiken TJ, Komjathy D, Rodriguez M, Stuckwisch A, Feils A, Subbotin V, Birstler J, Gillies SD, Rakhmilevich AL, Erbe AK, Sondel PM. Aiken TJ, et al. Among authors: rakhmilevich al. J Immunother Cancer. 2022 Jan;10(1):e003586. doi: 10.1136/jitc-2021-003586. J Immunother Cancer. 2022. PMID: 35039460 Free PMC article.
In situ Vaccine Plus Checkpoint Blockade Induces Memory Humoral Response.
Baniel CC, Heinze CM, Hoefges A, Sumiec EG, Hank JA, Carlson PM, Jin WJ, Patel RB, Sriramaneni RN, Gillies SD, Erbe AK, Schwarz CN, Pieper AA, Rakhmilevich AL, Sondel PM, Morris ZS. Baniel CC, et al. Among authors: rakhmilevich al. Front Immunol. 2020 Jul 24;11:1610. doi: 10.3389/fimmu.2020.01610. eCollection 2020. Front Immunol. 2020. PMID: 32849544 Free PMC article.
T-cell-independent antitumor effects of CD40 ligation.
Rakhmilevich AL, Alderson KL, Sondel PM. Rakhmilevich AL, et al. Int Rev Immunol. 2012 Aug;31(4):267-78. doi: 10.3109/08830185.2012.698337. Int Rev Immunol. 2012. PMID: 22804571 Free PMC article. Review.
Radiation to all macroscopic sites of tumor permits greater systemic antitumor response to in situ vaccination.
Carlson PM, Patel RB, Birstler J, Rodriquez M, Sun C, Erbe AK, Bates AM, Marsh I, Grudzinski J, Hernandez R, Pieper AA, Feils AS, Rakhmilevich AL, Weichert JP, Bednarz BP, Sondel PM, Morris ZS. Carlson PM, et al. Among authors: rakhmilevich al. J Immunother Cancer. 2023 Jan;11(1):e005463. doi: 10.1136/jitc-2022-005463. J Immunother Cancer. 2023. PMID: 36639155 Free PMC article.
A combined radio-immunotherapy regimen eradicates late-stage tumors in mice.
Rakhmilevich AL, Tsarovsky NW, Felder M, Zaborek J, Moram S, Erbe AK, Pieper AA, Spiegelman DV, Cheng EM, Witt CM, Overwijk WW, Morris ZS, Sondel PM. Rakhmilevich AL, et al. Front Immunol. 2024 Jul 15;15:1419773. doi: 10.3389/fimmu.2024.1419773. eCollection 2024. Front Immunol. 2024. PMID: 39076988 Free PMC article.
114 results